Related Experiment Video
Updated: Mar 31, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1
Xiaogang Liu1, Lihong Ma1, Qinhua Rao1
1Department of Gynaecology and Obstetrics, People's Hospital of Yuxi, Yuxi, Yunnan, China (mainland).
Background:
Ovarian cancer is the most lethal gynecological malignant cancer in the female genital system. The dysfunction of miRNA contributes to ovarian cancer development.
Material And Methods:
The miR-1271 level in ovarian cancer tissues and cells was assayed by qRT-PCR. The miR-1271 expression in cells was overexpressed by miRNA-mimic transfection and reduced by miRNA-antisense-oligonucleotide (ASO) transfection. Cell proliferation was analyzed by an MTT assay. The targeted genes were predicted by a bioinformatics algorithm and confirmed by a dual luciferase reporter assay. The protein level was assayed by Western blotting.
Results:
The ovarian cancer tissue and cell lines showed low levels of miR-1271. Low levels of miR-1271 in ovarian cancer tissues were correlated with a low rate of patient survival, and the overexpression of miR-1271 inhibited the proliferation of ovarian cancer cells. The 3' UTR of cyclin G1 (CCNG1) was targeted by miR-1271.
Conclusions:
Low levels of miR-1271 in ovarian cancer tissues promoted cancer cell growth. MiR-1271 may be a new predictor of prognosis in ovarian cancer. MiR-1271 exerted its role by targeting CCNG1.
Insights
Low levels of microRNA-1271 (miR-1271) in ovarian cancer promote tumor growth. Restoring miR-1271 may serve as a prognostic marker and therapeutic target for ovarian cancer.
Area of Science:
- Gynecology
- Oncology
- Molecular Biology
Background:
- Ovarian cancer is a leading cause of gynecological cancer deaths.
- MicroRNA (miRNA) dysfunction is implicated in ovarian cancer pathogenesis.
Purpose of the Study:
- To investigate the role of miR-1271 in ovarian cancer.
- To identify miR-1271 as a potential prognostic biomarker.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure miR-1271 levels.
- Transfection techniques to overexpress or inhibit miR-1271.
- MTT assay for cell proliferation analysis.
- Bioinformatics and dual luciferase reporter assay to identify targets.
- Western blotting for protein level assessment.
Main Results:
- Ovarian cancer tissues and cells exhibit reduced miR-1271 expression.
- Low miR-1271 levels correlate with poor patient survival.
- Overexpression of miR-1271 suppressed ovarian cancer cell proliferation.
- miR-1271 directly targets the 3' untranslated region (UTR) of cyclin G1 (CCNG1).
Conclusions:
- Reduced miR-1271 expression promotes ovarian cancer cell proliferation.
- miR-1271 shows potential as a prognostic indicator for ovarian cancer.
- miR-1271 exerts its tumor-suppressive function by targeting CCNG1.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
MicroRNAs
MicroRNAs
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

